Prokaryotic Collagen Therapeutics for Postoperative Adhesions
US-2018236141-A1 · Aug 23, 2018 · US
US11639377B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11639377-B2 |
| Application number | US-202017082525-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 28, 2020 |
| Priority date | Apr 23, 2020 |
| Publication date | May 2, 2023 |
| Grant date | May 2, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The disclosure discloses a preparation of type I collagen-like fibers and a method for regulating and controlling the periodic length of fiber stripes thereof, belonging to the technical field of genetic engineering. The disclosure produces a three-segment chimeric collagen P-CL-P pattern by inserting a continuous Gly-Xaa-Yaa triplet collagen sequence in the middle based on the N- and C-terminal (GPP)n sequences. The self-assembly is driven by the interaction between the N- and C-terminal (GPP)n triple helixes to form banded fibers with periodic bright and dark stripes. According to the method of the disclosure, a fiber from a clean source, which can self-assemble to form periodic bright and dark stripes can be prepared, the structure of which is similar to type I collagen, the preparation process is simple, the collagen fiber with low cost can be produced on a large scale, and the method has broad application prospects in the field of biological materials.
Opening claim text (preview).
What is claimed is: 1. A single-chain protein for expressing a type I-like collagen, wherein: the single-chain protein consists of an amino acid sequence as set forth in: V-domain has an amino acid sequence as set forth in SEQ ID NO:1; (GPP)n is (glycine-proline-proline)n; n=10; the CL-domain has an amino acid sequence as set forth in any sequence of SEQ ID NOS: 2 to 6; HIS is a 6×His tag; the V-domain and (GPP) n are ligated by LVPRGSP (SEQ ID NO:33); and the single-chain protein self-assembles with additional single-chain proteins to form the type I-like collagen fibers with D-periodic band structure comprising uniform spacing of bright and dark alternating stripes when viewed with electron microscope. 2. The single-chain protein according to claim 1 , wherein the bright and dark stripes have a length of p×1 nm, wherein p is an integer greater than 5. 3. A gene encoding the single-chain protein according to claim 1 . 4. A plasmid or a cell, wherein the plasmid comprises the gene according to claim 3 , and wherein the cell comprises the gene according to claim 3 . 5. The plasmid or the cell according to claim 4 , wherein the plasmid is a pColdIII series plasmid or a pET series plasmid. 6. The plasmid or the cell according to claim 4 , wherein the cell is an E. coli cell selected from the group consisting of: E. coli BL21, E. coli BL21 (DE3), E. coli JM109, E. coli DH5α, and E. coli TOP10. 7. A method for preparing type I collagen-like fiber, comprising the following steps: (1) culturing the cell of claim 4 under conditions that induce expression of the gene; (2) adding a trypsin to a purified gene product of step (1) and incubating at 20° C. to 25° C. for at least 6 hours to obtain the single-chain protein of the type I-like collagen; and (3) adding the single-chain protein of a type I-like collagen obtained in step (2) to a solution at a final concentration of 0.1 mmol/L to 1 mmol/L, and storing the solution at 2° C. to 37° C. 8. The method according to claim 7 , wherein the gene in step (1) has a nucleotide sequence as set forth in any one of SEQ ID NOS: 13 to 15, 17, and 18. 9. The method according to claim 7 , wherein the storing time in step (3) is 24 hours or more. 10. The method according to claim 7 , wherein in step (3), the collagen is added to the solution at a final concentration of 0.5 mmol/L, and storing the solution at 4° C. to 37° C. for at least 2 days.
Fusion polypeptide · CPC title
Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG] · CPC title
containing a His-tag · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.